Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations

Annals of Neurology

Volumn 20, Issue 6, 1986, Pages 665-670

  Mazurek, Michael F ^a   Bed, M Flint ^a   Bird, Edward D ^a   Martin, Joseph B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN;

ALZHEIMER DISEASE; AMNESIA; CENTRAL NERVOUS SYSTEM; ENDOCRINE SYSTEM; ETIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; HUMAN CELL; NEOCORTEX; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ARGIPRESSIN; BRAIN CHEMISTRY; FEMALE; HUMAN; IN VITRO; MALE; MIDDLE AGE; POSTMORTEM CHANGES; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022979301     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410200603     Document Type: Article

References (58)

1. Changes in brain catecholamines in patients with dementia of Alzheimertype
2. Mechanism of effect of hypoxia on renal water excretion
3. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of ageing and demented patients
4. 3H]Vasopressin binding to rat hippocampal synaptic plasma membrane
5. Vasopressin analogue (DDAVP) improves memory in human males
6. Argininevasopressin binding sites in rat brain: a quantitative autoradiographic study
7. Huntington's chorea: post‐mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia
8. Oxytocin, vasopressin and memory: opposite effects on consoldiation and retrieval processes
9. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia
10. Neurotransmitter‐related enzymes and indices of hypoxia in senile dementia and other abiotrophies
11. A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide
12. Coexistence of vasopressin, neurophysin and noradrenaline immunoreactivity in medium‐sized cells of the locus coeruleus and subcoeruleus in the rat
13. Vasopressin potentiates the stimulation of cyclic AMP accumulation by norepinephrine
14. Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density
15. Selective loss of central cholinergic neurones in Alzheimer's disease
16. Topography of binding sites for neurohypophyseal hormones in rat brain
17. The vasopressinergic innervation of the brain in normal and castrated rats
18. The importance of vasopressin in memory
19. Central target for the behavioural effects of vasopressin neuropeptides
20. What is the importance of vasopressin in memory processes?
21. Subcortical afferents of the nucleus accumbens septi in the cat, studied with retrograde axonal transport of horseradish peroxidase and bisbenzimid
22. Cortical afferents of the nucleus accumbens in the cat, studied with anterograde and retrograde transport techniques
23. Procedures for detecting outlying observations in samples
24. Effects of lesions in the hypothalamic paraventricular, supraoptic and suprachiasmatic nuclei on vasopressin and oxytocin in rat brain and spinal cord
25. Amygdaloid changes in aging and dementia
26. Vasopressin, oxytocin and neurophysins in the human brain and spinal cord
27. Changes in cerebrospinal fluid and plasma vasopressin in the febrile sheep
28. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde‐ and retrograde‐horseradish peroxidase study
29. The amygdalostriatal projection in the rat: an anatomical study by anterograde and retrograde tracing methods
30. Osmotic stress mimics effects of vasopressin on learned behaviour
31. Effect of vasopressin and oxytocin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic‐midbrain structures
32. Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat
33. CSF vasopressin concentration is reduced in Alzheimer's disease
34. Clinical diagnosis of Alzheimer's disease
35. Does vasopressin really facilitate memory processes?
36. Vasopressin excites hippocampal neurones
37. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat
38. 3H‐AVP binding sites in particulate preparations of rat brain
39. Neurotransmitter enzyme abnormalities in senile dementia
40. The influence of agonal status on some neurochemical activities of postmortem human brain tissue
41. A post‐mortem study of the cholinergic and GABA systems in senile dementia
42. Extra‐hypothalamic vasopressin in human brain
43. Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia
44. A critique of the vasopressin‐memory hypothesis
45. Loss of recent memory after bilateral hippocampal lesions
46. Carotid sinus pulse pressure, a determinant of plasma antidiuretic hormone concentration
47. Vasopressin‐ and neurophysin‐immunoreactive neurons in the septal region, medial amygdala and locus coeruleus in colchicine‐treated rats
48. Vasopressin, oxytocin and their related neurophysins
49. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders
50. Regional effects of vasopressin on rat brain catecholamine metabolism
51. Cell loss in the locus coeruleus in senile dementia of Alzheimer type
52. Identification of the vasopressin‐neurophysin II and oxytocin‐neurophysin I producing neurons in the bovine hypothalamus
53. Identification of the vasopressin‐neurophysin producing neurons of the rat suprachiasmatic nuclei
54. Interaction of vasopressin with the nigro‐striatal dopamine system: site and mechanism of action
55. Effects of vasopressin on human memory functions
56. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
57. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons
58. The neuroanatomy of amnesia: amygdala‐hippocampus vs. temporal stem